Granules India receives ANDA approval for Levetiracetam Tablets
Granules now has a total of 58 ANDA approvals from US FDA
Granules now has a total of 58 ANDA approvals from US FDA
Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Hampton joins PCC from Accord Healthcare, where he was the President and responsible for accelerating the firm's growth strategy
The superior Agilent 6495 Triple Quadrupole LC/MS (LC/TQ) System is ideal for demanding and challenging targeted analysis applications requiring the highest analytical sensitivity
The latest extension of Masimo and Philips’ ongoing collaboration will help enable clinicians to make quick and informed decisions without the need for additional monitoring equipment
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
Subscribe To Our Newsletter & Stay Updated